Journal of the American Academy of Orthopaedic Surgeons最新文献

Background: Magnetic resonance imaging (MRI) has revolutionized musculoskeletal care. However, its high costs and high utilization has prompted many insurance payors to require a prior authorization. This process remains burdensome and results in delays to patient care. The purpose of this study was to examine the relationship between several variables and the denial rate of outpatient MRI prior authorization requests from a single institution's department of orthopaedics.

Methods: MRI prior authorization insurance data was retrospectively collected from January 2019 to December 2022. Patient demographics, imaging characteristics, and insurance details were extracted and stratified into generalized categories. Analysis of variance, multivariate logistic regression models, and odds ratios (ORs) were used to predict the likelihood of request denial with α = 0.05.

Results: Of the 17,913 total MRI prior authorization requests identified, 885 (4.94%) were denied. Race and socioeconomic status were not markedly different between the authorized and denied cohorts; however, primary insurance payor, chief symptom, and anatomic location to be imaged were found to have notable differences between authorized and denied cohorts ( P < 0.0001). MRIs of the spine were less likely to be authorized compared with the shoulder (OR 0.51), upper extremity (OR 0.43), knee (OR 0.38), lower extremity (OR 0.34), and foot and ankle (OR 0.75) with P < 0.02 for each. Horizon NJ Health and Horizon Blue Cross Blue Shield, both Medicaid payors, were also less likely to authorize requests compared with other payors (Aetna, OR 0.37 and United Healthcare, OR 0.36) ( P < 0.01 for both).

Conclusion: The low denial rate of initial prior authorization requests over 4 years at our institution underscores the questionable utility of the prior authorization process. Our results are consistent with the current literature that has reported higher rates of denials for MRI prior authorization requests of the spine. Although we were not able to quantify the effect of these denials on patient care, the overall time required to process these requests undoubtedly causes delays in patient care. despite no notable difference seen in socioeconomic status, Horizon NJ Health, a major provider of only Medicaid insurance plans at our institution, was associated with a higher likelihood of denial. This suggests that MRI prior authorization requests submitted for Medicaid patients are more likely to be denied and cause an inequitable delay in care due to this process.

Introduction: The effect of social drivers of health (SDOH) on readmissions and costs after total hip arthroplasty (THA) and total knee arthroplasty (TKA) is poorly understood. Policies such as the Hospital Readmissions Reduction Program have targeted overall readmission reduction, using value-based strategies to improve healthcare quality. However, the implications of SDOH on these outcomes are not yet understood. We hypothesized that the area deprivation index (ADI) as a surrogate for SDOH would markedly influence readmission rates and healthcare costs in the 90-day postprocedural period for THA and TKA.

Methods: We used the 100% US fee-for-service Medicare claims data from 2019 to 2021. Patients were identified using diagnosis-related groups. Our primary outcomes included 90-day unplanned readmission after hospital discharge and cost of care, treated as "high cost" if > 1 standard deviation above the mean. The relationships between ADI and primary outcomes were estimated with logistic regression models.

Results: A total of 628,399 patients were included in this study. The mean age of patients was 75.6, 64% were female, and 7.8% were dually eligible for Medicaid. After full covariate adjustment, readmission was higher for patients in more deprived areas (high Area Deprivation Index (ADI)) (low socioeconomic status (SES) group OR: 1.30 [95% confidence intervals 1.23, 1.38]). ADI was associated with high cost before adjustment (low SES group odds ratio 1.08 [95% confidence intervals 1.04, 1.11], P < 0.001), although, after adjustment, this association was lost.

Discussion: This analysis highlights the effect of SDOH on readmission rates after THA and TKA. A nuanced understanding of neighborhood-level disparities may facilitate targeted strategies to reduce avoidable readmissions in orthopaedic surgery. Regarding cost, although there is some association between ADI and cost, this study may illustrate that ADI for THA and TKA is not sufficiently granular to identify the contribution of social drivers to elevated costs.

Proximal humerus reconstruction after oncologic resection is complex, with numerous muscular attachments, proximity of critical neurovascular structures, and dynamic stability granting multidirectional motion at the glenohumeral articulation. In skeletally immature patients, additional factors increase the complexity, including remaining limb growth and humerus size. Limb length discrepancy affects the limb's esthetics and function while the humerus size can limit fixation strategies and intramedullary device use. Reconstruction options used in isolation or combination include endoprostheses, osteoarticular allografts, allograft-prosthetic composites, autografts, and arthrodesis. Unique limb salvage options to address the unique factors in young, skeletally immature patients include vascularized fibular epiphyseal transfer, claviculo pro humeri, and expandible endoprostheses. Each option has advantages and disadvantages for anticipated function, durability, shoulder stability, and complications. This review aims to aid preoperative planning and decision making for surgeons and patients undergoing proximal humerus resection and reconstruction with notable remaining growth potential.

The original review article, published in 2006, describing leg length discrepancy after total hip arthroplasty commented that "equal leg length should not be guaranteed." There has been considerable advancement in surgical technique and technology over the past decade, allowing surgeons to "hit the target" much more consistently. In this interval paper, we review leg length discrepancy and introduce some technologies designed to mitigate this complication. In addition, we present challenging clinical scenarios in which perceived leg length may differ from true leg length and how these can be addressed with proper workup and surgical execution.

There is a general need among orthopaedic surgeons for practical advice on managing patients with bleeding disorders. Appropriate diagnosis and management of these disorders is paramount once discovered before, during, or after the patient's surgical course. Bleeding disorders disrupt the body's ability to control bleeding, commonly through platelet function and blood clotting. Normally, the vessel contracts and retracts once disruption of blood vessels occurs, limiting blood loss. Blood platelets adhere to exposed collagen, aggregate at the site, and obstruct blood loss. Because platelet aggregates are temporary, blood clotting is needed to back up the platelet plug and provide a milieu for the healing process that completes the hemostatic events. Disorders that interfere with any of these events can result in hemorrhage, drainage, or rebleeding. Bleeding disorders are a group of conditions, either hereditary or acquired, marked by abnormal or excessive bleeding and/or bruising. The most effective methods for assessing coagulation disorders include a detailed history and a series of blood tests. Clinical examination findings are notable but may be less specific. If a surgical patient has a bleeding disorder discovered preoperatively, postoperatively, or intraoperatively, treatments exist with medications, surgical management, interventional radiology procedures, and replacement therapy.

Background: Short-keeled tibial implants may be at higher risk of aseptic loosening. Stem augmentation has been suggested to improve its fixation. We aimed to assess whether this technique could decrease the loosening rate of such tibial implants.

Methods: We retrospectively studied the knees receiving stemmed versus nonstemmed versions of a short-keeled prosthesis. A total of 932 patients undergoing total knee arthroplasty using a Persona prosthesis with >24-month follow-up (mean 53.7) were included, of whom 212 were at high risk of loosening due to osteoporosis or high body mass index (BMI). The rate of tibial aseptic loosening in high-risk patients and in the whole cohort was compared between those with and without stem extension. Multivariable analysis was conducted to identify the risk factors of loosening.

Results: In the whole cohort, in 203 knees (21.8%), a cemented short stem was used, versus 729 knees (78.2%) without. The tibial implant revision rates for loosening were 2.06% and 0.99% for nonstemmed and stemmed cases, respectively ( P = 0.551). When the cohort was categorized based on the loosening risk factors, the loosening risk was significantly higher in the high-risk than in the low-risk group, regardless of stem status (log-rank test = 8.1, hazard ratio = 2.17, 95% CI = 1.78, 2.57, P = 0.005). 212 patients were at high risk of loosening, due to high BMI or osteoporosis, among whom the risk of aseptic loosening was higher when a stem was not used (log-rank = 32.1, hazard ratio = 4.95, 95% CI = 4.05, 5.86, P < 0.001). In multivariate analysis, osteoporosis, BMI ≥35, and smoking were correlated with loosening.

Conclusion: The failure rate was markedly lower in the stemmed group of the patients at elevated risk of aseptic loosening due to osteoporosis and/or high BMI. In the entire cohort, the risk of loosening in stemmed tibial implants was similar to the nonstemmed group. The findings support a protective role for the stem in patients at high risk of failure of the cemented tibial implant.

Level of evidence: III therapeutic.

The American Academy of Orthopaedic Surgeons, together with The Hip Society, American Association of Hip and Knee Surgeons, American College of Radiology, and American Physical Therapy Association, recently released the updated 2023 Management of Osteoarthritis of the Hip Evidence-Based Clinical Practice Guidelines. 8 recommendations and 9 options comprise these guidelines intended to optimize treatment outcomes in a patient population that is growing exponentially over time. In this article, we present case studies that illustrate utilization of the clinical practice guideline workgroup's evidence-based recommendations in clinical practice.